COR.NYSECencora, INC

Form 4: Cencora CEO Steven Collis Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Cencora's CEO, Steven H. Collis, exercised stock options and sold shares of common stock on July 16, 2024, according to a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 16, 2024, Steven H. Collis, the Chairman, President, and CEO of Cencora, Inc., exercised non-qualified stock options to acquire 10,755 shares of Cencora common stock at a price of $89.58 per share.
  • Simultaneously, Collis sold 10,755 shares of Cencora common stock at a price of $222.12 per share.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on December 18, 2023.
  • Following these transactions, Collis directly owns 285,088 shares of Cencora common stock and 75,281 derivative securities (non-qualified stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy, suggesting no immediate cause for alarm or excessive optimism.

Positives

  • The CEO's transactions are being conducted under a pre-arranged 10b5-1 trading plan, which promotes transparency and reduces concerns about insider trading.

Risks

  • While the transactions are under a 10b5-1 plan, large sales by a CEO could be perceived negatively by some investors.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
  • The use of Rule 10b5-1 trading plans is a widespread practice among corporate executives to manage their stock sales in a transparent and compliant manner.
  • Comparable companies such as McKesson and Cardinal Health also see regular Form 4 filings from their executives related to stock option exercises and sales.

Stakeholder Impact

  • The transactions could have a minor impact on shareholders, depending on how the market interprets the CEO's stock sales.
  • Employees may be interested in the CEO's stock activity as an indicator of company performance.

Key Dates

DateDescription
12/18/2023Date the Rule 10b5-1 trading plan was entered into by the reporting person.
12/21/2023Date the Company's 8-K was filed with the Security and Exchange Commission disclosing the Rule 10b5-1 trading plan.
07/16/2024Date of the stock option exercise and sale of shares.
07/17/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.